Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Drug Testing topic
No spam. Unsubscribe anytime.
BRN committee backs adding oral‑fluid (saliva) testing to probationers' testing options
Summary
The California Board of Registered Nursing(BRN) Enforcement, Investigations and Intervention Committee voted to add oral‑fluid testing as an alternate testing matrix for probationers, after a vendor presentation on accuracy, logistics and virtual collection.
Get email alerts on the Drug Testing topic
No spam. Unsubscribe anytime.
The Enforcement, Investigations and Intervention Committee of the California Board of Registered Nursing voted to include oral‑fluid testing as part of the testing suite for the probation program to align it with the board's intervention program.
The committee's decision followed a presentation by representatives of Vault (a contracted testing vendor) and technical remarks from a laboratory physician, who described oral fluid as a valid but "short" detection matrix best used alongside other testing methods. Committee member Allison Cormack moved to add oral‑fluid testing for probationers; David Lawler seconded. The motion passed with committee members recorded as voting yes.
Why it matters: committee members and staff said the change addresses access issues for probationers who live far from in‑person collection sites and mirrors options already available in the intervention program. Staff and the vendor emphasized oral fluid testing is not a one‑for‑one replacement for urine or hair testing because of differences in detection windows, specimen volume and laboratory confirmation processes.
How oral fluid testing works and limits: Vault's Dr. Ferguson explained oral fluid is distinct from plain "saliva," has variable composition and generally yields a narrow detection window of about 24–36 hours (rare exceptions may extend that). He said the sample volume is small, requiring laboratories to detect drugs at very low (nanogram) levels. Because there is currently no accepted validity test for oral fluid (unlike urine creatinine/specific gravity checks), proper collection technique and device performance are critical.
Vault recommended: (1) treat oral fluid as an alternative matrix, not a replacement; (2) use it as part of a randomized mix of matrices (urine, hair, blood spot/PETH, nails) to approach a "gold standard" of detection; (3) collect in person when feasible, but allow monitored virtual collections where necessary; and (4) avoid unconfirmed point‑of‑collection immunoassay results, relying instead on laboratory confirmatory testing and medical review.
Operational details discussed: Vault said virtual monitored collections are feasible and described their process: mailing kits (typically supplies for multiple tests, often five), live video monitoring during collection (monitors watch the donor unwrap kits, perform the swab, and seal specimens), FedEx return with tracking, and split‑specimen storage so a second lab can be used on request. Vault staff said they do not perform DNA testing on collected specimens; DNA testing exists but cannot substitute for secure, witnessed collections. Vault said oral fluid is generally the least expensive of the virtual matrices (comparable to urine), with nail and blood‑spot tests costing more.
Committee concerns and safeguards: staff and members stressed oral fluid's short detection window and the risk of overreliance. Enforcement Chief Shannon Johnson and committee members said oral fluid should be used within a randomized suite of tests and as a backstop for participants who cannot reach a collection site that day. Vault and Dr. Ferguson noted device‑specific laboratory certification is required and that laboratories are not yet as widely certified for oral fluid devices as they are for urine, hair, or blood.
What the committee authorized: the committee voted to include oral‑fluid testing among the testing options available to probationers to align probation practice with the intervention program. Staff indicated that implementation details (contracts, device and lab selection, monitoring protocols and participant logistics) will be handled by staff and the vendor and brought to the full board for awareness.
Next steps: staff and the vendor will continue operational planning, including expanding collection site coverage for rural counties and finalizing procedures for virtual monitored collection. Committee members suggested presenting the topic to the full board at its next meeting so board members can review implementation details and cost implications.

